Antibodies are amongst the most widely used tools in life science research, making antibody quality critical to generating reliable experimental data. As research becomes increasingly focused on reproducibility and data integrity, many scientists are choosing recombinant antibodies because they deliver consistent performance, dependable supply, and high specificity while eliminating the variability associated with traditional antibody production. Recombinant antibodies are also produced using animal-free expression systems, supporting more sustainable and ethical research practices.
What Are Recombinant Antibodies?
Recombinant antibodies are laboratory-produced from defined DNA sequences, enabling consistent specificity, performance, and reproducibility across production lots. Unlike traditional monoclonal antibodies produced from hybridoma cells, recombinant antibodies are expressed in vitro, eliminating cell-line drift and reducing batch-to-batch variability.
Because they are genetically engineered, recombinant antibodies can be optimized to offer improved sensitivity and performance. They are available in a range of formats, including purified and conjugated antibodies, with multiple species backbones, isotypes, and engineered variants to support diverse research applications.
Four Reasons to Switch to Recombinant Antibodies
Proven Specificity
Invitrogen™ antibodies undergo rigorous advanced verification using approaches like knockout, knockdown, relative expression, and cell treatment studies to help ensure target-specific detection and minimize off-target binding. Thermo Fisher Scientific offers one of the industry’s largest portfolios of advanced verified antibodies.
High Sensitivity and Performance
Invitrogen recombinant antibodies are engineered to enhance sensitivity while maintaining excellent specificity. Stronger signal intensity helps detect low-abundance proteins and supports applications including western blot, immunofluorescence, flow cytometry, and immunohistochemistry.
Reproducibility You Can Rely On
Defined DNA sequences eliminate hybridoma drift, helping ensure consistent performance from lot to lot. Researchers can confidently repeat experiments over months or years without concerns about changing antibody behavior.
Versatility and Scalability
Choose from Invitrogen recombinant antibodies in multiple species, isotypes, engineered Fc backbones, and purified or conjugated formats. Recombinant production methods also allow for large-scale manufacturing.
Why Choose Invitrogen Recombinant Antibodies?
Thermo Fisher Scientific offers one of the industry's broadest portfolios of recombinant antibodies, supported by decades of antibody expertise. Backed by extensive peer-reviewed citations, advanced verification, multiple engineered formats, and an Antibody Performance Guarantee, Invitrogen recombinant antibodies help researchers move confidently from discovery to translational research.
Frequently asked questions
What is the difference between recombinant and monoclonal antibodies?
Recombinant antibodies are produced from defined DNA sequences in expression systems, enabling consistent quality and performance. Traditional monoclonal antibodies are generated from hybridoma cell lines, which can introduce variability over time due to cell-line drift.
What is the difference between native and recombinant antibodies?
Native antibodies are produced naturally by immune cells in an organism, while recombinant antibodies are engineered in vitro from known gene sequences for precise control of structure, specificity, and reproducibility.
What are the functional applications of recombinant antibodies?
Recombinant antibodies are widely used in diagnostics, therapeutics, and research where reliability and batch-to-batch consistency are important, including immunoassays, flow cytometry, imaging, and target verification.
